Association of Environmental Uncertainty With Altered Decision-making and Learning Mechanisms in Youths With Obsessive-Compulsive Disorder.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 11 2021
Historique:
entrez: 29 11 2021
pubmed: 30 11 2021
medline: 18 1 2022
Statut: epublish

Résumé

Adults with obsessive-compulsive disorder (OCD) display perseverative behavior in stable environments but exhibit vacillating choice when payoffs are uncertain. These findings may be associated with intolerance of uncertainty and compulsive behaviors; however, little is known about the mechanisms underlying learning and decision-making in youths with OCD because research into this population has been limited. To investigate cognitive mechanisms associated with decision-making in youths with OCD by using executive functioning tasks and computational modeling. In this cross-sectional study, 50 youths with OCD (patients) and 53 healthy participants (controls) completed a probabilistic reversal learning (PRL) task between January 2014 and March 2020. A separate sample of 27 patients and 46 controls completed the Wisconsin Card Sorting Task (WCST) between January 2018 and November 2020. The study took place at the University of Cambridge in the UK. Decision-making mechanisms were studied by fitting hierarchical bayesian reinforcement learning models to the 2 data sets and comparing model parameters between participant groups. Model parameters included reward and punishment learning rates (feedback sensitivity), reinforcement sensitivity and decision consistency (exploitation), and stickiness (perseveration). Associations of receipt of serotonergic medication with performance were assessed. In total, 50 patients (29 female patients [58%]; median age, 16.6 years [IQR, 15.3-18.0 years]) and 53 controls (30 female participants [57%]; median age, 16.4 years [IQR, 14.8-18.0 years]) completed the PRL task. A total of 27 patients (18 female patients [67%]; median age, 16.1 years [IQR, 15.2-17.2 years]) and 46 controls (28 female participants [61%]; median age, 17.2 [IQR, 16.3-17.6 years]) completed the WCST. During the reversal phase of the PRL task, patients made fewer correct responses (mean [SD] proportion: 0.83 [0.16] for controls and 0.61 [0.31] for patients; 95% CI, -1.31 to -0.64) and switched choices more often following false-negative feedback (mean [SD] proportion: 0.09 [0.16] for controls vs 0.27 [0.34] for patients; 95% CI, 0.60-1.26) and true-positive feedback (mean [SD] proportion: 0.93 [0.17] for controls vs 0.73 [0.34] for patients; 95% CI, -2.17 to -1.31). Computational modeling revealed that patients displayed enhanced reward learning rates (mean difference [MD], 0.21; 95% highest density interval [HDI], 0.04-0.38) but decreased punishment learning rates (MD, -0.29; 95% HDI, -0.39 to -0.18), reinforcement sensitivity (MD, -4.91; 95% HDI, -9.38 to -1.12), and stickiness (MD, -0.35; 95% HDI, -0.57 to -0.11) compared with controls. There were no group differences on standard WCST measures and computational model parameters. However, patients who received serotonergic medication showed slower response times (mean [SD], 1420.49 [279.71] milliseconds for controls, 1471.42 [212.81] milliseconds for patients who were unmedicated, and 1738.25 [349.23] milliseconds for patients who were medicated) (control vs medicated MD, -320.26 [95% CI, -547.00 to -88.68]) and increased unique errors (mean [SD] proportion: 0.001 [0.004] for controls, 0.002 [0.004] for patients who were unmedicated, and 0.008 [0.01] for patients who were medicated) (control vs medicated MD, -0.007 [95% CI, -3.14 to -0.36]) on the WCST. The results of this cross-sectional study indicated that youths with OCD showed atypical probabilistic reversal learning but were generally unimpaired on the deterministic WCST, although unexpected results were observed for patients receiving serotonergic medication. These findings have implications for reframing the understanding of early-onset OCD as a disorder in which decision-making is associated with uncertainty in the environment, a potential target for therapeutic treatment. These results provide continuity with findings in adults with OCD.

Identifiants

pubmed: 34842925
pii: 2786681
doi: 10.1001/jamanetworkopen.2021.36195
pmc: PMC8630570
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2136195

Commentaires et corrections

Type : ErratumIn

Références

Curr Dir Psychol Sci. 2012 Feb;21(2):36-41
pubmed: 22457564
Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Aug;3(8):694-703
pubmed: 29706587
Am J Psychiatry. 2007 Feb;164(2):335-8
pubmed: 17267798
Brain. 2019 May 1;142(5):1471-1482
pubmed: 30726914
Perspect Psychol Sci. 2011 May;6(3):299-312
pubmed: 26168520
Psychol Rev. 2019 Mar;126(2):292-311
pubmed: 30676040
Depress Anxiety. 2011 Feb;28(2):166-72
pubmed: 21284070
J Am Acad Child Adolesc Psychiatry. 2010 Dec;49(12):1238-48, 1248.e1-5
pubmed: 21093773
Expert Rev Neurother. 2009 Aug;9(8):1133-46
pubmed: 19673603
J Child Psychol Psychiatry. 2015 Aug;56(8):837-47
pubmed: 25866081
Psychol Med. 2013 Feb;43(2):391-400
pubmed: 22578546
Brain Cogn. 2004 Apr;54(3):263-5
pubmed: 15050790
J Math Psychol. 2010 Feb 1;54(1):5-13
pubmed: 20495607
Br J Med Psychol. 1997 Dec;70 ( Pt 4):403-11
pubmed: 9429759
Acta Psychiatr Scand. 2000 Apr;101(4):281-5
pubmed: 10782547
Nat Commun. 2019 Jan 3;10(1):20
pubmed: 30604744
Psychiatry Res. 2007 Jan 15;149(1-3):121-8
pubmed: 17123634
Am J Psychiatry. 2006 Jul;163(7):1282-4
pubmed: 16816237
Psychol Med. 2017 May;47(7):1246-1258
pubmed: 28065182
Commun Biol. 2021 Jan 21;4(1):96
pubmed: 33479495
Shanghai Arch Psychiatry. 2016 Feb 25;28(1):28-34
pubmed: 27688641
Psychol Aging. 2013 Mar;28(1):35-46
pubmed: 22946523
Biol Psychiatry. 2007 Apr 15;61(8):946-51
pubmed: 17157271
Psychiatry J. 2016;2016:5480391
pubmed: 27597949
Neuroimage. 2015 Jan 1;104:347-54
pubmed: 25234119
J Psychiatr Res. 2008 May;42(6):507-14
pubmed: 17599358
Compr Psychiatry. 2012 Feb;53(2):167-75
pubmed: 21550029
Neuropsychopharmacology. 2015 Mar 13;40(5):1192-202
pubmed: 25425323
Neuron. 2017 Oct 11;96(2):348-354.e4
pubmed: 28965997
Biol Psychiatry. 2010 Jun 15;67(12):1178-84
pubmed: 20381015
Psychol Med. 2014 Apr;44(6):1121-30
pubmed: 23866289
Depress Anxiety. 2019 Feb;36(2):130-140
pubmed: 30375085
Psychopharmacology (Berl). 2019 Aug;236(8):2337-2358
pubmed: 31324936
Dev Sci. 2007 Sep;10(5):664-80
pubmed: 17683350
Acta Psychiatr Scand. 2007 May;115(5):380-7
pubmed: 17430416
Hum Brain Mapp. 2013 Aug;34(8):1956-70
pubmed: 22461182
J Math Psychol. 2017 Dec;81:80-97
pubmed: 29200501
Neuropsychopharmacology. 2012 Nov;37(12):2730-9
pubmed: 22871914
Psychon Bull Rev. 2017 Aug;24(4):1234-1251
pubmed: 27966103
Behav Ther. 2012 Sep;43(3):533-45
pubmed: 22697442
Neurosci Biobehav Rev. 2020 Jan;108:617-645
pubmed: 31821834
J Child Psychol Psychiatry. 2020 May;61(5):605-613
pubmed: 31749150
J Clin Invest. 2009 Apr;119(4):737-46
pubmed: 19339765
Psychol Med. 2018 Aug;48(11):1900-1908
pubmed: 29353562
PLoS Comput Biol. 2020 Sep 30;16(9):e1008276
pubmed: 32997659
Clin Psychol Rev. 2013 Dec;33(8):1163-71
pubmed: 24128603
J Affect Disord. 2017 Jan 01;207:32-37
pubmed: 27690351
PLoS Comput Biol. 2017 Apr 12;13(4):e1005440
pubmed: 28403139

Auteurs

Aleya A Marzuki (AA)

Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, United Kingdom.
Department of Psychology, University of Cambridge, Cambridge, United Kingdom.
International University Malaya-Wales, Kuala Lumpur, Malaysia.

Ivan Tomic (I)

Department of Psychology, University of Cambridge, Cambridge, United Kingdom.

Samantha Hiu Yan Ip (SHY)

Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.

Julia Gottwald (J)

Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, United Kingdom.
Department of Psychiatry, School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.

Jonathan W Kanen (JW)

Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, United Kingdom.
Department of Psychology, University of Cambridge, Cambridge, United Kingdom.

Muzaffer Kaser (M)

Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, United Kingdom.
Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, United Kingdom.

Akeem Sule (A)

Department of Psychiatry, School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.

Anna Conway-Morris (A)

Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge, United Kingdom.

Barbara J Sahakian (BJ)

Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, United Kingdom.
Department of Psychiatry, School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.

Trevor W Robbins (TW)

Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, United Kingdom.
Department of Psychology, University of Cambridge, Cambridge, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH